rs41280965

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_004722.4(AP4M1):​c.228C>T​(p.Pro76Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00705 in 1,614,124 control chromosomes in the GnomAD database, including 71 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0063 ( 6 hom., cov: 31)
Exomes 𝑓: 0.0071 ( 65 hom. )

Consequence

AP4M1
NM_004722.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -2.15

Publications

6 publications found
Variant links:
Genes affected
AP4M1 (HGNC:574): (adaptor related protein complex 4 subunit mu 1) This gene encodes a subunit of the heterotetrameric AP-4 complex. The encoded protein belongs to the adaptor complexes medium subunits family. This AP-4 complex is involved in the recognition and sorting of cargo proteins with tyrosine-based motifs from the trans-golgi network to the endosomal-lysosomal system. [provided by RefSeq, Jul 2008]
AP4M1 Gene-Disease associations (from GenCC):
  • AP-4 deficiency syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hereditary spastic paraplegia 50
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • AP4-related intellectual disability and spastic paraplegia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 7-100102755-C-T is Benign according to our data. Variant chr7-100102755-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 210209.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.15 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00628 (956/152284) while in subpopulation NFE AF = 0.00863 (587/68016). AF 95% confidence interval is 0.00805. There are 6 homozygotes in GnomAd4. There are 471 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AP4M1NM_004722.4 linkc.228C>T p.Pro76Pro synonymous_variant Exon 3 of 15 ENST00000359593.9 NP_004713.2 O00189

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AP4M1ENST00000359593.9 linkc.228C>T p.Pro76Pro synonymous_variant Exon 3 of 15 1 NM_004722.4 ENSP00000352603.4 O00189

Frequencies

GnomAD3 genomes
AF:
0.00628
AC:
956
AN:
152166
Hom.:
6
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00125
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00275
Gnomad ASJ
AF:
0.0291
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00145
Gnomad FIN
AF:
0.0142
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.00863
Gnomad OTH
AF:
0.00574
GnomAD2 exomes
AF:
0.00729
AC:
1832
AN:
251464
AF XY:
0.00723
show subpopulations
Gnomad AFR exome
AF:
0.00148
Gnomad AMR exome
AF:
0.00185
Gnomad ASJ exome
AF:
0.0265
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0152
Gnomad NFE exome
AF:
0.00926
Gnomad OTH exome
AF:
0.00831
GnomAD4 exome
AF:
0.00714
AC:
10431
AN:
1461840
Hom.:
65
Cov.:
33
AF XY:
0.00712
AC XY:
5175
AN XY:
727230
show subpopulations
African (AFR)
AF:
0.00108
AC:
36
AN:
33480
American (AMR)
AF:
0.00197
AC:
88
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0262
AC:
686
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00146
AC:
126
AN:
86258
European-Finnish (FIN)
AF:
0.0160
AC:
856
AN:
53412
Middle Eastern (MID)
AF:
0.0127
AC:
73
AN:
5768
European-Non Finnish (NFE)
AF:
0.00732
AC:
8137
AN:
1111970
Other (OTH)
AF:
0.00710
AC:
429
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
623
1246
1868
2491
3114
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
274
548
822
1096
1370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00628
AC:
956
AN:
152284
Hom.:
6
Cov.:
31
AF XY:
0.00633
AC XY:
471
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.00125
AC:
52
AN:
41562
American (AMR)
AF:
0.00275
AC:
42
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.0291
AC:
101
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00145
AC:
7
AN:
4826
European-Finnish (FIN)
AF:
0.0142
AC:
151
AN:
10610
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.00863
AC:
587
AN:
68016
Other (OTH)
AF:
0.00568
AC:
12
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
52
103
155
206
258
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00872
Hom.:
5
Bravo
AF:
0.00531
Asia WGS
AF:
0.00173
AC:
7
AN:
3478
EpiCase
AF:
0.00840
EpiControl
AF:
0.00895

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Oct 24, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Sep 21, 2015
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

AP4M1: BP4, BP7, BS2 -

Hereditary spastic paraplegia 50 Benign:2
Jan 15, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 20, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary spastic paraplegia Benign:1
Jan 17, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
8.1
DANN
Benign
0.76
PhyloP100
-2.2
Mutation Taster
=293/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.13
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41280965; hg19: chr7-99700378; COSMIC: COSV57996466; COSMIC: COSV57996466; API